Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology

Carregando...
Imagem de Miniatura

Data

2020-11-01

Autores

Ramos, Paulo Muller [UNESP]
Anzai, Alessandra
Duque-Estrada, Bruna
Melo, Daniel Fernandes
Sternberg, Flavia
Nogueira Santos, Leopoldo Duailibe
Alves, Lorena Dourado
Mulinari-Brenner, Fabiane

Título da Revista

ISSN da Revista

Título de Volume

Editor

Elsevier B.V.

Resumo

Background: Alopecia areata is a highly frequent disease with an impact on quality of life and several treatment options with little clinical confirmatory evidence. Objective: To disseminate the recommendations of Brazilian dermatologists with expertise in the treatment of alopecia areata. Methods: Eight specialists with expertise in alopecia areata from different university centers were appointed by the Brazilian Society of Dermatology to reach a consensus on its treatment. Based on the adapted DELPHI methodology, the relevant elements were considered; then, an analysis of recent literature was carried out and the consensus was written down. Consensus on the management of alopecia areata was defined with the approval of at least 70% of the panel. Results/Conclusions: Intralesional injectable corticotherapy was considered the first optionfor localized disease in adults. In extensive cases with signs of activity, systemic cortico-steroid therapy should be considered and can be used together with immunosuppressants (corticosteroid-sparing agents). The use of an immunosensitizer (diphencyprone) is an option for stable long-term cases. Evaluation of side effects is as important as the rate of hair regrowth. (C) 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana, S.L.U.

Descrição

Palavras-chave

Adrenal cortex hormones, Alopecia areata, Consensus, Methotrexate, Therapeutics

Como citar

Anais Brasileiros De Dermatologia. New York: Elsevier Science Inc, v. 95, p. 39-52, 2020.